Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Meyers

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Cardiology|June 16, 2005
Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapiesC Daniel Meyers, Moti L Kashyap
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Management of the metabolic syndrome-nicotinic acidC Daniel Meyers, Moti L Kashyap
Current Opinion in Cardiology|June 26, 2004
Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protectionC Daniel Meyers, Moti L Kashyap
Current Opinion in Lipidology|November 6, 2004
Niacin therapy in atherosclerosisC Daniel Meyers, Vajinath S Kamanna, Moti L Kashyap
Atherosclerosis|September 2, 2006
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flushC Daniel Meyers, Paul Liu, Vaijinath S Kamanna, et al.
Annals of Internal Medicine|December 18, 2003
Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemiaC Daniel Meyers, Molly C Carr, Sang Park, et al.
Journal of Lipid Research|August 19, 2003
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDLC Daniel Meyers, Lisa R Tannock, Thomas N Wight, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Cardiology|June 16, 2005
Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapiesC Daniel Meyers, Moti L Kashyap
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Management of the metabolic syndrome-nicotinic acidC Daniel Meyers, Moti L Kashyap
Current Opinion in Cardiology|June 26, 2004
Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protectionC Daniel Meyers, Moti L Kashyap
Current Opinion in Lipidology|November 6, 2004
Niacin therapy in atherosclerosisC Daniel Meyers, Vajinath S Kamanna, Moti L Kashyap
Atherosclerosis|September 2, 2006
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flushC Daniel Meyers, Paul Liu, Vaijinath S Kamanna, et al.
Annals of Internal Medicine|December 18, 2003
Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemiaC Daniel Meyers, Molly C Carr, Sang Park, et al.
Journal of Lipid Research|August 19, 2003
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDLC Daniel Meyers, Lisa R Tannock, Thomas N Wight, et al.
Pageof 1